药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Isopropamide
Seratrodast
The metabolism of Zanubrutinib can be increased when combined with Seratrodast.
Isopropamide
Fosaprepitant
The metabolism of Zanubrutinib can be increased when combined with Fosaprepitant.
Isopropamide
Lumefantrine
The metabolism of Zanubrutinib can be increased when combined with Lumefantrine.
Isopropamide
Clevidipine
The metabolism of Zanubrutinib can be increased when combined with Clevidipine.
Isopropamide
Tesmilifene
The metabolism of Zanubrutinib can be increased when combined with Tesmilifene.
Isopropamide
Metamizole
The metabolism of Zanubrutinib can be increased when combined with Metamizole.
Isopropamide
Esketamine
The metabolism of Zanubrutinib can be increased when combined with Esketamine.
Isopropamide
Sarilumab
The metabolism of Zanubrutinib can be increased when combined with Sarilumab.
Isopropamide
Lesinurad
The metabolism of Zanubrutinib can be increased when combined with Lesinurad.
Isopropamide
Eslicarbazepine acetate
The metabolism of Zanubrutinib can be increased when combined with Eslicarbazepine acetate.
Isopropamide
Glycerol phenylbutyrate
The metabolism of Zanubrutinib can be increased when combined with Glycerol phenylbutyrate.
Isopropamide
Rufinamide
The metabolism of Zanubrutinib can be increased when combined with Rufinamide.
Isopropamide
Oritavancin
The metabolism of Zanubrutinib can be increased when combined with Oritavancin.
Isopropamide
Metreleptin
The metabolism of Zanubrutinib can be increased when combined with Metreleptin.
Isopropamide
Armodafinil
The metabolism of Zanubrutinib can be increased when combined with Armodafinil.
Isopropamide
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Zanubrutinib.
Isopropamide
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Zanubrutinib.
Zuclopenthixol
Imlifidase
The therapeutic efficacy of Trastuzumab deruxtecan can be decreased when used in combination with Imlifidase.
Zuclopenthixol
Ebola Zaire vaccine (live, attenuated)
The therapeutic efficacy of Ebola Zaire vaccine (live, attenuated) can be decreased when used in combination with Trastuzumab deruxtecan.
Zuclopenthixol
Belantamab mafodotin
The risk or severity of adverse effects can be increased when Trastuzumab deruxtecan is combined with Belantamab mafodotin.